Standard Biotools (LAB) EBT Growth (1y) (2011 - 2026)
Standard Biotools (LAB) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | -29.12% |
| 2 | Stryker | 129.50 Bn | 126.03 Bn | 4.50 Bn | 53.94% |
| 3 | Medtronic | 119.85 Bn | 110.63 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 73.79 Bn | 73.25 Bn | 3.85 Bn | 12.65% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 29.89% |
| 6 | Dexcom | 34.58 Bn | 32.64 Bn | 830.00 Mn | 31.69% |
| 7 | GE HealthCare Technologies | 34.14 Bn | 32.03 Bn | 2.18 Bn | 13.05% |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | 71.38% |
| 9 | Steris | 23.23 Bn | 22.74 Bn | 684.20 Mn | 17.94% |
| 10 | Standard Biotools | 258.06 Mn | -218.66 Mn | 10.54 Mn | -17.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17.25% |
| Mar 31, 2026 | 37.78% |
| Dec 31, 2025 | -84.36% |
| Sep 30, 2025 | -50.91% |
| Jun 30, 2025 | 28.04% |
| Mar 31, 2025 | 26.66% |
| Dec 31, 2024 | 186.91% |
| Sep 30, 2024 | -4.08% |
| Jun 30, 2024 | -51.77% |
| Mar 31, 2024 | -93.18% |
| Dec 31, 2023 | -91.07% |
| Sep 30, 2023 | 30.50% |
| Jun 30, 2023 | 74.31% |
| Mar 31, 2023 | 78.43% |
| Sep 30, 2022 | 43.58% |
| Jun 30, 2022 | -70.77% |
| Mar 31, 2022 | -275.08% |
| Sep 30, 2021 | -755.77% |
| Jun 30, 2021 | -169.44% |
| Mar 31, 2021 | -23.00% |